Radiolabeled TSPO Targeted Molecular Probe in Glioma
NCT07106008 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 8
Last updated 2025-08-06
Summary
Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium \[68Ga\]-DOTA-HK-011 in inflammation imaging of glioma.
Conditions
- Glioma (Any Grade) in the Brain
Sponsors & Collaborators
-
Nanjing First Hospital, Nanjing Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2026-08-31
- Completion
- 2026-08-31
More Related Trials
-
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression
NCT06975332 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
NCT00253448 ·Status: COMPLETED ·Phase: PHASE2
-
MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme
NCT01851733 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
NCT04899908 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
G207 Followed by Radiation Therapy in Malignant Glioma
NCT00157703 ·Status: COMPLETED ·Phase: PHASE1
-
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
NCT03830151 ·Status: RECRUITING ·Phase: PHASE1
-
Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
NCT02120287 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
NCT00004262 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
NCT01120639 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression
NCT06828341 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Anlotinib to Malignant Brainstem Glioma
NCT04668508 ·Status: UNKNOWN ·Phase: PHASE2
-
Proteome-based Personalized Immunotherapy of Glioblastoma
NCT01759810 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
NCT00114140 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00053183 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma
NCT06831773 ·Status: RECRUITING ·Phase: NA
-
Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
NCT00004017 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade Glioma
NCT07306299 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of 177Lu-PSMA-617 in People With Gliomas
NCT07223034 ·Status: RECRUITING ·Phase: PHASE1
-
Nimotuzumab in Adults With Glioblastoma Multiforma
NCT00753246 ·Status: COMPLETED ·Phase: PHASE3
-
INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
NCT02104882 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma
NCT00387790 ·Status: COMPLETED ·Phase: PHASE2
-
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
NCT07150806 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00022256 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial
NCT03082846 ·Status: COMPLETED ·Phase: NA
-
Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
NCT05023551 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1